for the six months ended 31 December 2022 -- 1 of 71 -- 2 2 Y E A R S 1 0 Y E A R S Global risks interconnection map Global risks ranked by severity over the short and long term GLOBAL RISK LANDSCAPE High Medium Low Nodes Risk influence Edges Relative influence High Medium Low Prolonged economic downturn Adverse outcomes of frontier technologies Digital power concentration Digital inequality Breakdown of critical information infrastructure Widespread cybercrime and cyber security Terrorist attacks Misinformation & disinformation Use of weapons of mass destruction Interstate conflict Geoeconomic confrontation Ineffectiveness of multilateral institutions Environmental damage incidents Failure to mitigate climate change Biodiversity loss & ecosystem collapse Natural resource crisis Failure of climate-change adaption Collapse of systematically important supply chain Natural disasters & extreme weather Large-scale involuntary migration State collapse Proliferation of illicit economic activity Chronic health conditions Employment crises Failure to stabilize price trajectories Debt crises Cost of living crises Asset bubble burst Erosion of social cohesion Severe mental health deterioration Infectious diseases Collapse or lack of public infrastructure and services Geopolitical Societal Technological Economic Environmental Risk categories Cost-of-living crisis 1 Natural disasters and extreme weather events 2 Geoeconomic confrontation 3 Failure to mitigate climate change 4 Erosion of social cohesion and societal polarisation 5 Large-scale environmental damage incidents 6 Failure of climate change adaption 7 Widespread cybercrime and cyber insecurity 8 Natural resources crises 9 Large-scale involuntary migration 10 Failure to mitigate climate change 1 Failure of climate change adaption 2 Natural disasters and extreme weather events 3 Biodiversity loss and ecosystem collapse 4 Large-scale involuntary migration 5 Natural resources crises 6 Erosion of social cohesion and societal polarisation 7 Widespread cybercrime and cyber insecurity 8 Geoeconomic confrontation 9 Large-scale environmental damage incidents 10 Geopolitical Societal Technological Economic Environmental Risk categories -- 2 of 71 -- 3 GLOBAL Normalised operating profit Core new business +15% to R11 061m +22% to R5 930m Normalised headline earnings +30% to R3 747m Headline earnings -9% to R2 981m Excluding discontinued products like VitalityInvest and Ping An Health reinsurance business Total income from non-insurance +51% to R2 528m -- 3 of 71 -- 4 GLOBAL Core new business +15% to R11 061m Normalised headline earnings +30% to R3 747m Headline earnings -9% to R2 981m 1 2 3 Evolving the model to create a platform for strong future growth Strong growth in quality earnings, driven by the efficacy of the Vitality shared-value model and in line with the target operating model Focus on financial prudence and immunisation from a volatile interest rate environment 4 Strong performance removes need for VCP; and given strong growth dynamics a dividend is premature but will be revisited at the end of the financial year Normalised operating profit +22% to R5 930m Total income from non-insurance +51% to R2 528m -- 4 of 71 -- 5 ESTABLISHED EMERGING NEW Organic Growth ModelVitality Shared-value business modelModel remains resilient in face of evolving global trends NATURE OF RISK TECHNOLOGY SOCIAL RESPONSIBILITY For our clients: • Better value • Improved health and behaviour outcomes For our businesses: • Product differentiation and competitive advantage • Superior growth • Better persistency • Lower mortality/claims • Superior operating profit growth (CPI + 10%) • No recourse to additional capital • Ensuring shareholder value created • Capital strength, liquidity and return on capital THE DYNAMICS OF THE BUSINESS AND OPERATING MODELS L E A D S T O : Customer engagement, superior lapses and mortality experience Operating profit growth of CPI+10% with new business growth New initiative materiality and progress Capital strength and appropriate cash generation -- 5 of 71 -- 6 Health 1 825 +4% 4 442 +23% 693 +18% Life 2 518 +30% 1 485 +17% Invest 592 +15% 1 505 -1% Insure 4 -73% 616 +3% Bank -398 -20% 706 +71% Other SA New -148 -15% 356 -21% SA 4 414 +23% 8 566 +15% 1 399 +40% Vitality Health 867 +2% 890 +26% Vitality Life 536 +48% 801 +45% UK New -126 +17% UK 1 277 +15% 1 691 +34% Vitality Network 199 +52% VHI - Ping An Health1 84 -40% 804 -12% VHI - Other -44 -51% VG 239 +33% 804 -12% 1 1292 +69% Strong new business growth, profit impacted by once-off costs Excellent growth with Individual Life up 11% and a recovery in Group Life Robust despite weak market performance Continued elevated claims experience Profit sustained off a high base despite excellent new business growth Excellent growth driven by strong operating variances Strong growth from deepened partner relationships Tough market conditions, however business fundamentals remain strong Continued growth in clients and increasing share of new credit card credit Amplify Health made first acquisition Operating loss impacted by run-down cost of VitalityInvest New business impacted by a large scheme transfer into UF in prior period STRONG OPERATING PERFORMANCE Operating profit New business 1 PAH own licence 2 VG income excludes cost recoveries and rewards +22% R5 930m +15% R11 061m Total Excl products in run down Income +51% R2 528m ZARm -- 6 of 71 -- 7 STRONG OPERATING PERFORMANCE Total income from non- insurance business lines R2 528m Operating profit R5 930m Core new business API R11 206m - 1 000 2 000 3 000 4 000 5 000 6 000 H1 2004 H1 2005 H1 2006 H1 2007 H1 2008 H1 2009 H1 2010 H1 2011 H1 2012 H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 - 2 000 4 000 6 000 8 000 10 000 12 000 H1 2004 H1 2005 H1 2006 H1 2007 H1 2008 H1 2009 H1 2010 H1 2011 H1 2012 H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 - 500 1,000 1,500 2,000 2,500 3,000 H1 2020 H1 2021 H1 2022 H1 2023 Rm Rm Rm 18% CAGR from 2004 11% CAGR from 2004 -- 7 of 71 -- 8 NEW INITIATIVE SPEND REVERTED TO TARGET Investment in New reverted to guidance % core operating profit (UK includes VitalityInvest) Amplify Health had strong profits offsetting other VG New; excluding this, majority of New is in Bank and VG VG New Excl Amplify Health Amplify Health Total VG New Mainly made up of Vitality USA and V1 Breakdown of New (excl Amplify Health and VitalityInvest) Breakdown of VG New UK 52% 19% SA other 27% VG excl Amplify Health 2% UK excl VitalityInvest 11% 0% 5% 10% 15% 20% 25% H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 -- 8 of 71 -- 9 UNIQUE ABILITY TO ENGAGE CLIENTS Duration Engagement improves over time Quality Engagement beyond just activity Scale High engagement across markets 0% 20% 40% 60% 80% 100% Market 1 Market 2 South Africa Market 3 Market 4 Market 5 Market 6 United Kingdom Market 7 Market 8 Market 9 Market 10 Market 11 Market 12 Market 13 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Month 1 Month 6 Month 12 Month 24 Engagement index across all markets -100% -50% 0% 50% 100% Market 1 Market 2 Market 3 Market 4 Market 5 Market 6 Market 7 Market 8 Market 9 Market 10 SA UK Market 11 Market 12 Market 13 Non-physical activity Physical activity -- 9 of 71 -- 10 SIGNIFICANT STATUS CORRELATIONS Lapses No VD Blue Bronze Silver Gold Diamond No VD Blue Bronze Silver Gold Diamond None Blue Bronze Silver Gold Diamond Deposits Arrears 94% Lower arrears rate 9x Higher average deposits 43% Lower paid-ups 70% Lower withdrawals 55% Lower claims 77% Lower lapses 15% Lower claims 45% Lower lapses 38% Lower claims 55% Lower lapses None Blue Bronze Silver Gold Diamond Claims Life insurance Health insurance Motor insurance Long-term savings Banking Blue Bronze Silver Gold Blue Bronze Silver Gold Blue Bronze Silver Gold Blue Bronze Silver Gold Blue Bronze Silver Gold and Diamond Blue* Bronze Silver Gold and Diamond -- 10 of 71 -- 11 GROUP EMBEDDED VALUE Group revenue attributable to Emerging and New 28% 14.4% Annualised ROEV Opening EV VNB Unwind of discount rate Non-economic experience variances and methodology and assumption changes Operational EV Economic experience variances & methodology & assumption changes Other Closing EV R92 459m R93 986m R86 258m Operational EV Economic and other Positive non-economic experience variances Total Lapses* 171 Renewal expenses 71 Mortality and morbidity 320 Premium and Fee Income 239 Inflation-linked indexation 393 Other 609 Total 1 803 *Lapses, surrenders and policy alterations -- 11 of 71 -- 12 EXCESS SHAREHOLDER CASH GENERATION WAS USED TO REPAY DEBT R7.5bn Cash generated from in-force (R6.9bn) Cash used net of finre funding Cash generated from in-force business R7.5bn -R1.0bn Tax -R4.5bn New business net finre -R0.8bn New Initiatives -R0.8bn Finance costs and dividends Cash generated Cash used R552m Vitality Life Vitality Health Discovery Life and Invest Discovery Health Net cashflow before paying debt Decision to repay debt given excess shareholder cash generation Businesses generate sufficient cash R0.6bn Net cash before debt Cash conversion1 1 Normalised operating profit after tax over cash generated from operations less spend on new business less tax before business development spend 0% 10% 20% 30% 40% 50% 60% 70% H120 H121 H122 H123 -- 12 of 71 -- 13 CASH GENERATION RECOVERING AND WELL CAPITALISED Strongly capitalised FLR within target DHMS solvency (unaudited) 35.1% Dec 21 Cover Dec 22 Cover Life 1.8x 1.8x Insure 1.8x 1.4x VH 1.9x 1.5x VL 2.2x 2.2x Bank1 1.4x 1.2x PAH2 2.1x 2.7x 1 Capital Adequacy Ratio 2 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission 3 Centre cash + undrawn committed facilities Cash generation recovery Cash generated before dividends and debt and excl. shares issued and once-off’s (R millions) 18% 20% 22% 24% 26% 28% 30% FY17 H1 18 FY18 H1 19 FY19 H1 20 FY20 H1 21 FY21 H1 22 FY22 H1 23 FLR 22% 28% ( 800) ( 600) ( 400) ( 200) 0 200 400 600 800 H1 20 H1 21 H1 22 H1 23 Sufficient liquidity 0 500 1,000 1,500 2,000 H1 FY21 H1 FY22 H1 FY23 Centre liquidity3 , R millions -- 13 of 71 -- 14 GIVEN GROWTH DYNAMICS, PREMATURE TO REINSTATE DIVIDEND Theoretical dividend framework The COVID-19 period (2020 – 2022) Current period under review % operating profit Dividend cover ESTABLISHED EMERGING NEW 90% 20% -10% Philosophy Funded from the dividend In line with market No dividend -1x Dividend cover ~ 4x 2-3x 0x • Investment in New c20%, mainly DSY Bank R5 930m 18% 23% 28% FY20 H121 FY21 H122 FY22 H123 0% 10% 20% H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 FY22 FY23 FY24 FY25 FY26 FY27 Before new business acquisition cost Profit before tax • Dividend paused • Desire to reduce debt • R1.5bn Ping An Health capital injection Operating profit Prudence Growth H1 2002 H1 2003 H1 2004 H1 2005 H1 2006 H1 2007 H1 2008 H1 2009 H1 2010 H1 2011 H1 2012 H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 R552m Cashflow before debt repaid 26% to 22% Financial leverage ratio 21% to 11% Invested in New CY 23 Bank monthly operational break-even (upside scenario) • Immunised against interest rate volatility (1 000) ( 500) 0 500 1 000 H1 20 H1 21 H1 22 H1 23 -- 14 of 71 -- 15 CASH USED TO INVEST IN FUTURE GROWTH R7.5bn Cash generated from in-force (R6.9bn) Cash used net of finre funding R0.6bn Net cash flow before debt Cash generated from in-force business R7.5bn -R1.0bn Tax -R4.5bn New business net finre -R0.8bn New Initiatives -R0.8bn Finance costs and dividends Cash generated Cash used R552m Vitality Life Vitality Health Discovery Life and Invest Discovery Health Net cashflow before paying debt New business IRR* RFR + 9.4% *Weighted average RFR across the Group 1 2 VS -- 15 of 71 -- 16 REPORTED PROFIT AFFECTED BY INTEREST RATES Rm 6 months ended Dec 2022 6 months ended Dec 2021 % Normalised profit from operations before economic assumptions adjustments 5,930 4,872 +22% Economic assumptions adjustment DL -862 498 Economic assumptions adjustment VL -38 -46 Time value of money of VitalityLife interest rate swaption -86 60 Forex and gains/(losses) on foreign exchange contracts not designated as a hedge 30 227 Finance charges excl. 1DP finance lease -792 -698 Vaccination costs 0 -137 Other (including IFRS reporting adjustments) 68 -55 Profit before tax 4,250 4,721 -10% Tax -1,307 -1,416 Profit attributable to preference shareholders -31 -28 Headline earnings adjustment 69 1 Headline earnings 2,981 3,278 -9% Economic assumptions adjustment (DL and VL) after tax and hedging 659 -321 Other 107 -81 Normalised headline earnings 3,747 2,876 +30% -- 16 of 71 -- 17 INTEREST RATES IMPACT EARNINGS, BUT NO IMPACT ON OPERATIONS Interest rate volatility Earnings Liquidity Solvency Discovery Life VitalityLife 0% 5% 10% 15% 0 4 8 12 16 20 24 28 32 36 40 44 48 Annualised Spot Rate Years from valuation Nominal Spot Rate Curve Jun 22 JSE (cash flow weighted single rate 12.25%) Dec 22 JSE (cash flow weighted single rate 11.75%) 1 Year to date economic assumption impact on IFRS earnings before discretionary margin changes 2 weeks prior Valuation Date 2 weeks after cR400m Relative gain cR600m Relative gain IFRS earnings impact1 sensitive to level and shape of yield curve *Nominal and real rates 0.5% drop* Base 0.5% increase* Cashflow immaterially impacted by changes in rates (assuming constant CPI) Shape of yield curve changed, particularly at long end Solvency coverage immaterially impacted 0.5% drop* Base 0.5% increase* *Nominal and real rates Hedge limits downside to rates falling and upside in margins Hedge protects against large negative cashflow risk VLL solvency resilient to stresses 25 Year SONIA swap rate Significant interest rate volatility -200 -100 - 100 200 1.0% 1.3% 1.6% 1.9% 2.2% 2.5% 2.8% 3.1% 3.4% 3.7% 4.0% 4.3% 4.6% 4.9% 5.2% 5.5% Cashflow with hedge Cashflow with no hedge 0% 100% 200% 300% No Hedge With Hedge -200 -150 -100 -50 0 50 100 1.0% 1.3% 1.6% 1.9% 2.2% 2.5% 2.8% 3.1% 3.4% 3.7% 4.0% 4.3% 4.6% 4.9% 5.2% 5.5% Margin Generated with Hedge IFRS with hedge IFRS with no hedge Margin Generated with no hedge 0% 1% 2% 3% 4% 5% 31/12/19 29/02/20 30/04/20 30/06/20 31/08/20 31/10/20 31/12/20 28/02/21 30/04/21 30/06/21 31/08/21 31/10/21 31/12/21 28/02/22 30/04/22 30/06/22 31/08/22 31/10/22 -- 17 of 71 -- 18 GLOBAL Normalised operating profit Core new business +15% to R11 061m +22% to R5 930m Normalised headline earnings +30% to R3 747m Headline earnings -9% to R2 981m Excluding discontinued products like VitalityInvest and Ping An Health reinsurance business Total income from non-insurance +51% to R2 528m -- 18 of 71 -- -- 19 of 71 -- 20 VITALITY PLATFORM -- 20 of 71 -- 21 USING CAUSAL INFERENCE WITH NOVEL INSIGHTS 502 062 members Study over 2013 - 2019 Causal Forest Death (𝑡2) (Outcome) Physical activity points (𝑡1) (Treatment) Age (𝑡0) Vitality Status (𝑡0) Duration on Vitality Total Claims (𝑡0) RUB (𝑡0) Socio- economic score (𝑡0) Chronic Count (𝑡0) PA Points per Week (𝑡0) Isolating the impact of exercise Key insights: how exercise reduces risk -36% -40% -49% -80% -30% 20% 0 (base) Low Medium High -27% -50% -61% -100% -50% 0% 0 (base) Low Medium High Age 45-65 Age 65+ Relative Mortality Relative Mortality 12% -44% -55% -100% -50% 0% 50% 0 Base Medium High Relative Mortality Age 45-65 Impact of PA increases as you get older Maintenance is important for already active members Significant improvements as PA increases 36.6bn exercise points earned -15% -67% -60% -80% -60% -40% -20% 0% 0 (base) Low Medium High -56% -63% -63% -65% -60% -55% -50% 0 (base) Low Medium High Unadjusted mortality Age 45-65 Age 65+ Includes selection and behaviour change -- 21 of 71 -- 22 HABIT INDEX PREDICTS LONG-TERM BEHAVIOUR CHANGE Classify habits and analyse transitions over time Deeper understanding of the value equation Identify habit Time Habit formation Look back x weeks and establish overall habit Generate a habit index that changes over time based on exercise patterns 𝐻𝐼 = 𝑅2 × 𝐸𝑝𝑤 Exercised Did not exercise Track how member exercises over 7-week period Strong Weak Bad Good Habit Strength Habit type ∆ 𝑉𝑎𝑙𝑢𝑒 = ∆ 𝑞𝑥 ∆ ℎ𝑎𝑏𝑖𝑡 × ∆ ℎ𝑎𝑏𝑖𝑡 𝑟𝑒𝑤𝑎𝑟𝑑 − ∆ 𝑝𝑟𝑒𝑚𝑖𝑢𝑚 Observe a net positive habit improvement over time Persistency and strength of habit determines value created 6 weeks of behaviour is enough to establish a habit -- 22 of 71 -- 23 -- 23 of 71 -- 24 THREE STRATEGIC STRANDS -- 24 of 71 -- 25 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health New business +15% to R8 566m Operating profit +23% to R4 414m -- 25 of 71 -- 26 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 26 of 71 -- 27 H1 FY20 H2 FY20 H1 FY21 H2 FY21 H1 FY22 H2 FY22 H1 FY23 Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 DISCOVERY BANK Net income Retail deposits Advances Operating result >1.3m R12.7bn R4.8bn -R398m Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 Jul-19 Dec-19 May-20 Oct-20 Mar-21 Aug-21 Jan-22 Jun-22 Nov-22 Total clients >580k *Includes capital development costs during build phase -700 -600 -500 -400 -300 -200 -100 0 H1 FY19* H1 FY20 H1 FY21 H1 FY22 H1 FY23 New Business Acquisition Costs Loss excl. new business acquisition costs +51% vs H1 FY22 +66% vs H1 FY22 +33% vs H1 FY22 +19% vs H1 FY22 R706m +71% vs H1 FY22 Total accounts Graph shows total clients -- 27 of 71 -- 28 SIGNIFICANT GROWTH ± 1000 daily new business sales Average daily new business sales per business day Superior new business product mix Increasing % of new business weighted towards Credit Card and Suite 0 100 200 300 400 500 600 700 800 900 1000 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Incl. Jan 23 H1 FY22 H1 FY23 17% 38% 35% 10% 14% 40% 28% 18% Savings PAYT Bundled CC and Suite Increasing engagement/NIR by tenure NIR pcpm for different products Indexed to month 1 378% 177% 139% 80% 100% 120% 140% 160% 180% 200% 220% 1 2 3 4 5 6 7 8 9 10 11 12 PAYT Bundled CC and Suite Opportunity to increase overall revenue Revenue pcpm vs Big 4 400% 180% 160% 140% 120% 100% 80% 0 50 100 150 200 250 300 350 400 450 DSY Bank 1 Bank 2 Bank 3 Bank 4 DSY Average Big 4 NIR pcpm Overall Revenue pcpm Big 4 Average -- 28 of 71 -- 29 EXCEPTIONAL CLIENT QUALITY Income distribution of new business Increasing % of higher income earners H1 FY22 H1 FY23 37% 50% 10% 3% New credit card market share 5% 15% Q1 FY 21 Q3 FY21 Q1 FY22 Q3 FY22 Q1 FY23 Growing new credit market share Superior and improving credit quality Credit loss ratio vs market 1.8% 5.3% Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Big 4 ave* 30% 50% 14% 7% 0-10k 10k-50k 50k-100k R100k+ Income per month June 2022 -- 29 of 71 -- 30 ECONOMICS OF GROWTH Operating leverage Indexed to FY22 Q1 66% 107% 45% Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Expenses pcpm Gross NIR pcpm Loss before tax pcpm* *Once-off adjustments allocated evenly over the financial year 1.0 1.2 1.5 1.5 1.5 Blue Bronze Silver Gold Diamond Banking vs insurance growth Estimated trajectory of client growth rebased at 100 High value derived from more engaged clients NIR pcpm after cost of incentives by status Indexed to Blue VM status 0 1000 2000 3000 4000 5000 6000 7000 1 2 3 4 5 6 7 8 9 10 Time since launch Average financial services company illustrative Discovery Bank actual Discovery Bank illustrative -- 30 of 71 -- 31 -0.5 - 0.5 1.0 1.5 2.0 (0.15) (0.10) (0.05) - 0.05 0.10 0.15 0.20 0.25 0.30 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Jan-24 Mar-24 May-24 Jul-24 Sep-24 Nov-24 Jan-25 Mar-25 May-25 Jul-25 Sep-25 Nov-25 Jan-26 Mar-26 May-26 Jul-26 Sep-26 Nov-26 Jan-27 Mar-27 May-27 Clients Profit before tax (Base) Profit before tax (Upside) -0.5 - 0.5 1.0 1.5 2.0 (0.10) (0.05) - 0.05 0.10 0.15 0.20 0.25 0.30 0.35 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Jan-24 Mar-24 May-24 Jul-24 Sep-24 Nov-24 Jan-25 Mar-25 May-25 Jul-25 Sep-25 Nov-25 Jan-26 Mar-26 May-26 Jul-26 Sep-26 Nov-26 Jan-27 Mar-27 May-27 ATTRACTIVE RETURNS AND PROFITABILITY Business case sensitivities: R1bn-R1.2bn p.a. operating profit in 3 years Key financial levers Average income pcpm (Rands) Expenses growth (%; current references yoy normalised growth; base/upside references medium-term CAGR) Model efficacy: CLR (%, excl. overlays) Growth: clients and daily new business (*average daily new business) Economics to generate R1bn-R1.2bn p.a in 3 years Advances pc (Rands) 1k* 1k* ±1.4k* 0 500 1,000 1,500 2,000 Current Base Upside 0 8,000 16,000 24,000 32,000 Current Base Upside 0 100 200 300 Current Base Upside 2.0% 2.5% 3.0% Current Base Upside 0% 5% 10% Current Base Upside Operating profit (Rm) Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors Operating profit (Rm) Operating profit before tax and new business acquisition costs p.m. Operating profit before tax p.m. R100 million R100 million Base Upside Clients (m) Clients (m) -- 31 of 71 -- 32 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 32 of 71 -- 33 DISCOVERY HEALTH Membership New business Non-scheme growth Operating profit >3.8m +23% >290k +4% lives under administration to R4 442m lives to R1 825m 1993 1996 1999 2002 2005 2008 2011 2014 2017 2020 Non Scheme Products Restricted Schemes DHMS Jan-18 Jul-18 Jan-19 Jul-19 Jan-20 Jul-20 Jan-21 Jul-21 Jan-22 Jul-22 Flexicare Gap Cover Healthy Company H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 15% of total revenue -- 33 of 71 -- 34 0% 2% 4% 6% 8% 10% 12% 2018 2019 2020 2021 2022 DHMS DISCOVERY HEALTH MEDICAL SCHEME (DHMS) PERFORMANCE SUMMARY Membership Stable plan movements and lapses market share 57.6% Stable lapses 5.5% Plan upgrades / downgrades 1 DHMS Rest of Industry Others Annualised lapse rate excludes turnover members: i.e. members from existing employer groups who leave their employment and are subsequently replaced Robust growth Gross lives Withdrawing Lives Left employer Affordability Provider change Death Emigration Other Movement to dependant ~338k lives ~312k lives Gross activations and withdrawing lives in 2022 94.6% 2.9% 2.5% 94.5% 2.6% 2.9% 94.6% 2.4% 3.0% 96.5% 1.9% 1.6% 2018: 2019: 2020: 2021: 2022: 97.1% 1.6% 1.3% -- 34 of 71 -- 35 SOLVENCY BUILT UP | PROTECTING MEMBERS AND THE SCHEME Illustrative example based on sample scheme that was priced correctly for an operating breakeven in 2019 Solvency position Cost curve Indexed at January 2019 -40% -30% -20% -10% 0% 10% 20% 30% 40% 50% 60% 2019 2020 2021 2022 2023 2024 2025 2026 Solvency Required solvency Healthcare discontinuities during COVID-19 caused a reserve build up What options are available to manage the excess solvency? 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2019 2020 2021 2022 2023 2024 2025 Underlying medical cost inflation = 10% ~(CPI+4%) -- 35 of 71 -- 36 SOLVENCY BUILT UP | PROTECTING MEMBERS AND THE SCHEME SCENARIO 1: Price for inflation at 6% during 2021, 2022 and 2023 rather than 10% Solvency position Cost curve Indexed at January 2019 Ignoring real underling inflation during the pandemic: scheme reaches point of no return within one year 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2019 2020 2021 2022 2023 2024 2025 -40% -30% -20% -10% 0% 10% 20% 30% 40% 50% 60% 2019 2020 2021 2022 2023 2024 2025 2026 Solvency Required solvency Solvency drops rapidly, with scheme insolvent by 2024 25% increase in contributions required in 2024 to bridge gap Actuarial death spiral: Young and healthy drop out by 2025 and sick remain Contribution increases at 6%: 2021-23 Medical inflation Underlying medical cost inflation = 10% ~(CPI+4%) -- 36 of 71 -- 37 SOLVENCY BUILT UP | PROTECTING MEMBERS AND THE SCHEME SCENARIO 2: DHMS approach to return excess solvency to members through deferrals & WELLTH fund Solvency position Cost curve 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2019 2020 2021 2022 2023 2024 2025 Jan -21 Jul-21 -40% -30% -20% -10% 0% 10% 20% 30% 40% 50% 60% 2019 2020 2021 2022 2023 2024 2025 2026 Solvency Returned to members Required solvency Deferred contributions & WELLTH Fund used to return excess solvency Deferrals ensured affordability for members Scheme correctly priced, avoiding any future price shocks DHMS contribution deferral strategy Medical inflation Jan -22 Oct -22 Jan -23 Apr -23 Indexed at January 2019 Matching underlying inflation throughout the pandemic: contribution increases less than 10% in all years -- 37 of 71 -- 38 PROTECTING MEMBERS AND THE SCHEME | Suppressed screening and preventative healthcare during COVID-19 had severe health implications, leaving people with undiagnosed risks Proportion of eligible members screening Preventative screening materially reduced over COVID-19 Fewer early-stage cancers due to a lack of screening Higher severity at diagnosis of diabetes Number of members diagnosed with cancer Proportion of new diabetes diagnoses with complex conditions 2018 2019 2020 2021 2022 Mammograms Pap Smear Prostate Screening Health Check Pre-COVID-19 Since COVID-19 Stage 1 Stage 2 Stage 3 Stage 4 -11% early stage 30.5% 33.5% Pre-COVID-19 Since COVID-19 +10% Once-in-lifetime funding to reset health understanding R1.4bn investment in members’ health, funded by reserves Up to R10 000 in discretionary wellness benefits, for all existing and new policies across all plans -- 38 of 71 -- 39 THE NEED FOR A RESILIENT HEALTHCARE SYSTEM IS MORE APPARENT THAN EVER Discovery is supportive of healthcare reform to address unacceptable levels of inequality in access to quality healthcare 1 2 The NHI Fund can be a valuable tool to build on public- private partnerships developed during the COVID-19 pandemic 3 Although the envisaged implementation of NHI is incremental and long-term, LCBOs present an immediate opportunity to progress universal health coverage 4 Discovery has proposed a blended funding model, that can achieve NHI policy objectives with less risk -- 39 of 71 -- 40 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 40 of 71 -- 41 DISCOVERY LIFE Normalised operating profit New business API Maintained leading market share position +30% to R2 518m H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 +17% to R1 485m NMG Market Share survey Q3 2022 12 months to Sep 2021 27.2% 26.9% 12 months to Sep 2022 Group life returned to profitability Individual life: +11% Life and Invest EV RoEV annualised +14.8% Jun-22 Dec-22 R 38.4bn R 40.9bn -- 41 of 71 -- 42 POSITIVE CASH GENERATION AND VARIANCES Premium and Fees Claims Operational costs Cashflows from existing New business strain Net Finre Net Cashflow Strong cashflow generation (Life and Invest) R9 445m R2 179m R688m Persistency Mortality & Morbidity Premium & fee income Other Total Non-economic Economic Total H1 14 H2 14 H1 15 H2 15 H1 16 H2 16 H1 17 H2 17 H1 18 H2 18 H1 19 H2 19 H1 20 H2 20 H1 21 H2 21 H1 22 H2 22 H1 23 Mortality Morbidity 100% Positive variances Discovery Life (Rm) Gross AvE (vs pre-COVID-19 assumptions) Net of -R163m morbidity variance in Individual Life R296m Mortality trending to pre- COVID levels Elevated morbidity primarily driven by increase in volume and severity of ICB claims Mortality trending to pre-COVID levels, elevated morbidity VNB and margin impacted by interest rate volatility and lower volumes* VNB (Rm) Life: VNB margin (%) Life: 227 169 H1 2022 H1 2023 6.8% 4.5% H1 2022 H1 2023 *Excludes ACIs and servicing Cash flow equates to c30% of net of tax normalised earnings -- 42 of 71 -- 43 None Low-moderate engagement High engagement Actual H1 2023 Long term expected None Low-moderate engagement High engagement Actual H1 2023 Long term expected POWERFUL SHARED-VALUE DYNAMICS Based on study by global reinsurer Comparable portfolio refers to fully underwritten risk providers 87% 144% 103% 100% 186% 123% Pre-COVID-19 (2015- 2019) COVID-19 (2020- 2021Q3) Total (2015-2021Q3) Discovery Comparable portfolio -13% Improved experience dynamics through engagement, consistent with status-based assumptions Positive engagement dynamics amplified through the pandemic Independent study by global reinsurer confirms lower relative increase in mortality through COVID-19 period Lapse experience Mortality experience *Market comparison from global reinsurer study 20% DSY lower than competitors in a comparable portfolio* 13% DSY lower than competitors in a comparable portfolio* -42% -20% -- 43 of 71 -- 44 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 44 of 71 -- 45 11% lower income drawdowns in shared-value benefits accrued and paid to clients R16.1bn Since the launch of shared value: 22% lower investment lapses DISCOVERY INVEST H1 FY 19 H1 FY 20 H1 FY 21 H1 FY22 H1 FY23 +15% to R592m Normalised operating profit H1 FY 19 H1 FY 20 H1 FY 21 H1 FY22 H1 FY23 -1% to R1 505m New business Shared-value outcomes 0 20 40 60 80 100 120 140 160 180 Discovery Rest of market Higher net flows growth than the rest of the market1 Jul-18 Feb-19 Sep-19 Apr-20 Nov-20 Jun-21 Jan-22 Aug-22 +3% to R131bn Assets under administration 1 Source: ASISA; Retail and funds of funds net flows at 30 September each year rebased at 100 on 30 September 2016 Indexed to 100 at Sept 2016 -- 45 of 71 -- 46 COMPELLING BUSINESS CASE 0 20 40 60 80 100 120 140 160 Jan-20 Apr-20 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Discovery Invest Umbrella Funds Strong assets under administration growth Consistent margin Leveraging Shared-value model to drive growth Discovery Invest Consistent architecture and Shared-value model Assets under administration per month Operating profit to assets rebased at 100 Discovery Invest income protection boosts Cogence income protection boosts 0 20 40 60 80 100 120 H1 FY20 H1 FY21 H1 FY22 H1 FY23 Blue Bronze Silver Gold Diamond +12.5% +20% +30% +40% +50% Blue Bronze Silver Gold Diamond +7.5% +12.5% +15% +20% +25% -- 46 of 71 -- 47 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 47 of 71 -- 48 Gross new business Gross written premium to R2 579m1 to R616m2 1 Personal lines figures only 2 Figures excluding VAT 3 Normalised operating profit includes Personal lines but excludes Cambridge Mobile Telematics (CMT), Sigfox and Bi-ME +3% +11% Market share in GWP Assuming 6% annual market growth 7% Vehicles insured +1% to 295 066 Normalised operating profit to R21m3 -38% H1 FY19 H1 FY20 H1 FY21 H1 FY22 H1 FY23 H1 FY19 H1 FY20 H1 FY21 H1 FY22 H1 FY23 H1 FY17 H1 FY18 H1 FY19 H1 FY20 H1 FY21 H1 FY22 H1 FY23 H1 FY19 H1 FY20 H1 FY21 H1 FY22 H1 FY23 DISCOVERY INSURE H1 FY19 H1 FY20 H1 FY21 H1 FY22 H1 FY23 -- 48 of 71 -- 49 EXPECT MARGIN RECOVERY AFTER REPRICING ACTION Model is working Loss ratio by Vitality status Lapses by status 100 89 73 66 57 Blue Bronze Silver Gold Diamond Actual vs motor repair cost rebased at 100 90 95 100 105 110 115 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-22 May-22 Sep-22 Motor repair cost Premium Pricing mismatch during COVID-19 0 50 100 150 200 250 - 500 1 000 1 500 2 000 Q1 FY 21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Load shedding hours Loss ratio indexed (RHS) Load shedding impacts on power surge claims Proportion of high-risk vehicles in total claims and new business Ongoing pressure from power surge and theft 5% 11% 40% 45% 0% 50% 100% H2 FY21 H1 FY22 H2 FY22 H1 FY23 Other High-risk vehicle models High-risk vehicles NB (rebased) 0 20 40 60 80 100 120 140 Jul-21 Sep-21 Nov-21 Jan-22 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Out-of-anniversary assumption Actual Data-driven repricing action Lapsed clients have a relatively higher loss ratio MTI Lapsed Retained 40% 100 85 57 30 21 Blue Bronze Silver Gold Diamond -10% -8% -6% -4% -2% 0% 2% 4% 6% 8% 10% H1 18 H2 18 H1 19 H2 19 H1 20 H2 20 H1 21 H2 21 H1 22 H2 22 H1 23 H2 23 F Operating profit glidepath Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors -- 49 of 71 -- 50 Vitality Health Vitality Car Vitality Life New business +34% to R1 691m Operating profit +15% to R1 277m -- 50 of 71 -- 51 UK COMPOSITE Normalised operating profit1 Earned premiums Lives covered New business +16% +11% +15% +35% to £62.7m to £483.6m to 1.66m lives to £83m New generation insurer offering best-in-breed products across businesses and operating as a fully integrated composite business with a seamless and intuitive client journey Vitality Health Vitality Car Vitality Life 1 Including Vitality Invest, group initiatives and head office costs H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions -- 51 of 71 -- 52 VITALITY HEALTH Normalised operating profit Earned premiums Lives covered New business +3% +26% to £42.5m to £305.5m to 903k lives to £43.7m H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions +12% +18% -- 52 of 71 -- 53 Cash from inforce book New Business acquisition New Projects Net cash generated POSITIVE ACTUARIAL AND OPERATING RESULTS Good cash generation Continued excellent retention strategy Causal relationship between engagement and healthcare costs Lapse rates Relative healthcare costs by level of engagement H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 100 82 84 79 82 82 Musculoskeletal Oncology Cardiac -31% -37% -46% Active Rewards points £65m £21.3m Authorisations returned to pre-COVID-19 levels Monthly authorisations per 1000 lives 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 PRE COVID Jun-20 Sep-20 Dec-20 Mar-21 Jun-21 Sep-21 Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Cardiac Musculoskeletal Oncology Mental Health Total -- 53 of 71 -- 54 WELL POSITIONED FOR FURTHER GROWTH IN THE UK HEALTHCARE ENVIRONMENT Greater value placed on PMI cover Current state of the NHS Source: The Economist; NHS England; Financial Times Growth of VH PMI lives 100,000 200,000 300,000 400,000 500,000 600,000 700,000 800,000 900,000 H1 2013 H1 2015 H1 2017 H1 2019 H1 2021 H1 2023 Structural and environmental difficulties 2 3 4 5 6 7 8 Millions 7.1 million (Nov ‘22) People waiting to receive treatment 0% 10% 20% 30% 40% 50% 60% 70% 2017 2018 2019 2020 2021 2022 Vitality GP Talking therapies ODA Physiotherapy 60% in 2022 Percentage of claims that are Primary Care Surge in demand for Primary Care services -- 54 of 71 -- 55 IMPROVING THE EFFICIENCY OF HEALTHCARE DELIVERY Sophisticated analytical, technology and health management assets Advanced digital pathways. Intelligent matching with the right person at the right time Obtain instant online authorisation for care digitally through Vitality GP and Care Hub Research, compare and book with highly rated consultants using the intelligent Consultant Finder tool Proactive reach-out to members to assist engaging with Vitality and accessing healthcare First insurer to introduce a virtual GP Introduced physiotherapy, talking therapies, optical, dental and audiology benefits All accessible via single source through CareHub Smart Service – digital-first engagement journey Vitality GP Talking Therapies Physiotherapy > > > > Expansive primary care. -- 55 of 71 -- 56 VITALITY LIFE Normalised operating profit Earned premiums Lives covered New business +49% +45% to £26.3m to £178.1m to 758k lives to £39.3m H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 GBP millions +9% +11% -- 56 of 71 -- 57 STRONG OPERATING PERFORMANCE IN A COMPLEX ECONOMIC ENVIRONMENT Exceptional sales performance despite rising inflation Continued excellent retention strategy Strong growth in new business market share Sales of index-linked policies rebased to Jan 2022 Lapses AvE Average market share of new business volumes Source: NMG UK Risk Distribution Monitor Intervened against ‘high lapse’ brokers Restructured franchise channel Consolidated ops and service at Group level Enhanced retention capabilities Strengthened actuarial bases and set up COVID-19 provisions Entered into interest rate hedge Deferred Part VII transfer Changed Group legal entity structure Adapted elements of actuarial methodology Sourced liquidity funding in the UK Area Management actions 1 2 3 4 5 6 7 8 9 10 OPERATIONS CAPITAL LIQUIDITY Addressed the 10-point plan 5.0% 5.5% 6.0% 6.5% 7.0% 7.5% 2020 2021 2022 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 Expected -18.8% CPI 0.0 0.5 1.0 1.5 2.0 2.5 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Policy sales CPI doubled since Jan Policy sales largely unaffected -- 57 of 71 -- 58 USA New business* -12% to R804m Operating profit +33% to R239m Income +69% to R1 129m *PAH’s insurance licence business -- 58 of 71 -- 59 Vitality Global VITALITY GLOBAL Strong underlying growth, driven by deepened partner relationships, broadening the reach of Vitality assets and capabilities Vitality Network Vitality Health International Africa USA Operating result +15% to $13.8m +33% to R239m Vitality Network Vitality Health International H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 -- 59 of 71 -- 60 VITALITY NETWORK Continued growth driven by product innovation, delivery excellence through Vitality 1 and the deepening of successful partnerships Vitality Global Vitality Network -- 60 of 71 -- 61 VITALITY NETWORK Integrated API by insurance partners Revenue Operating profit Insurance partners membership -7% to $709m H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 +7% to R12.3bn +20% to $35.3m +38% to R613m +33% to $11.5m +52% to R199m +24% to 3.4m H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 11% increase in margin YoY H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 -- 61 of 71 -- 62 GROWTH SUPPORTED BY ASIAN MARKET RECOVERY POST COVID AND EXPANSION WITH PARTNERS 1 3 Expansion into South America by enabling a total wellness ecosystem with Prudential, leveraging the V1 technology 4 A more comprehensive rollout of Vitality with Manulife in Canada 2 Continued success and market expansion with our partners, and a partnership with the second largest life insurer in India reaching > 43 000 lives in 3 months Growth in Asian Pacific regions as markets continue to recover from the Pandemic, with membership growth of 11% for AIA 1 -- 62 of 71 -- 63 VITALITY HEALTH INTERNATIONAL Investment towards growing early growth businesses in health insurance and health tech in key markets Vitality Global Vitality Network Vitality Health International Africa USA -- 63 of 71 -- 64 VHI LEVERAGES THE SUCCESS OF THE MATURE PAH TO INVEST INTO HIGH POTENTIAL HEALTH MARKETS USA Operating result -29% to $2.3m -18% to R40m Vitality Health International Year of launch or investment by VG 2020 2022 2022 2009 2008 *section follows on slide AFRICA HEALTH Revenue +99% to $29.7m VHI excluding PAH H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 +13% VHI - Other VHI – PAH includes Amplify Health revenue from IP fees for health IP Including PAH equity earnings H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 -- 64 of 71 -- 65 BROADENING IMPACT & BUILDING GLOBAL DIGITAL HEALTH CAPABILITIES Continued expansion into markets and creating partnerships with leading rewards partners While overall pre-tax profits were down 44% to R624m, PAH licence written premiums for the period increased 14% to R14bn. The decline in overall profits was driven largely by the poor performance of the Shanghai Stock Exchange causing a 46% decline in investment income Initial revenue fees from the sale of IP earned in H1 of 2023. Expanding on existing market-leading capabilities through the acquisition of a Singapore-based leading AI and machine learning solutions provider, with superior AI solutions & cloud services Rapid build of health tech capabilities and early positive feedback from market on new capabilities Following successful solution delivery in Australia, the business is pursuing opportunities to expand into the UK and Asia USA AFRICA HEALTH -- 65 of 71 -- 66 1.4% 1.7% 1.4% 1.2% Q1 Q2 Q3 Q4 ECONOMIC ENVIRONMENT IMPACTED BY EXTENSIVE COVID WAVE First Omicron wave is subsiding COVID restrictions in place for most of 2022 Source 1: Local government websites, Gavekal Dragonomics/Macrobond; Source 2: Reuters; Source: 3 Wu Zunyou, the chief epidemiologist at the China Center for Disease Control, Reuters 21 January; Source 4: New York Times, 15 February – models based on 1) the prior Shanghai outbreak, 2) travel patterns 4) recent testing data 4) US death rate; Source 5 Bernhard Schwartländer, epidemiologist; Source 6: CCDC. Source 7: Economist Intelligence Unit, January 2023 Economic environment expected to rebound7 • Population infection rate: ~80%3 • Official cumulative deaths: 83,1504 • Estimated cumulative deaths: 500k – 1.5m4,5 • Peak COVID hospitalisations: 1.625m (5 Jan 23)6 0 500000 1000000 1500000 2000000 2500000 3000000 3500000 01/07/2022 01/08/2022 01/09/2022 01/10/2022 01/11/2022 01/12/2022 01/01/2023 01/02/2023 01/03/2023 31-03-23 01-07-22 3.5mn 01-10-22 01-01-23 • Restrictions varied from city-wide lockdowns to more open movement with 72-hour PCR testing • Rapid removal of restrictions in December and now completely lifted • 308m domestic tourism trips during Lunar new year2 GDP growth performance 2023 GDP growth forecast (%change QoQ) Driven by consumption and investment 0.00 0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan-23 Shanghai in full lockdown Shanghai starts to reopen “10 new measures” to ease policy “20 new measures” to ease policy Protests Official downgrading of Covid response Quarantine for int’l arrivals dropped Lockdown intensity index in top 100 Cities (GDP weighted)1 Projected daily COVID-19 infections (IHME) 2018 2019 2020 2021 2022 2023 2024 Actual Forecast 3.0% 5.7% 01-22 01-23 -- 66 of 71 -- 67 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 PAH licence Reinsurance H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 Investment income and gains Profit before investment income and gains PING AN HEALTH PAH’s operating results pre- tax Discovery’s operating result after tax Written premium1 New business1 -44% -40% +0% -37% to R624m (DSY’s share is R107m) to R84m R20.4bn to R3.6bn 1 100% of PAH H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 PAH licence Reinsurance -46% growth in investment income -12% growth in PAH licence business +14% growth in PAH licence written premium -37% -- 67 of 71 -- 68 Q1 Q2 Q3 Q4 Investment income Q1 Q2 Q3 Q4 Profit from operations PING AN HEALTH REMAINS RESILIENT SUPPORTED BY STRONG BUSINESS FUNDAMENTALS High quality metrics Profits impacted by negative investment performance and conservative reserving approach * As defined by the China Banking and Insurance Regulatory Commission 93.6% Combined Operating Ratio 219% Core solvency ratio* 266% Comprehensive solvency ratio* RMB11bn Insurance contract reserves as at 31 Dec 2022 -- 68 of 71 -- 69 RAPID ESTABLISHMENT OF LEADING DIGITAL HEALTH SOLUTIONS ACCELERATED BY A SUCCESSFUL ACQUISITION OF AIDA 1 3 Acquisition of AiDA accelerating expansion in Asia and provides commercially proven solutions with strong synergies with Amplify Health IP 4 7 products identified for development, with 3 prioritised (Smart Claims, Chronic Disease Management platform and Data Foundation) due to clear demand from local markets 2 Transfer of IP and talent is largely complete with leadership and management roles fully staffed Revenue and capital model appropriate and fit for expansion: up to $200m of build and acquisition costs funded in return for IP and talent transfer 1 5 Positive discussions being held with 4 markets and early-stage interest shown by various private healthcare businesses including large regional hospital groups -- 69 of 71 -- 70 GLOBAL Core new business +15% to R11 061m Normalised headline earnings +30% to R3 747m Headline earnings -9% to R2 981m 1 2 3 Evolving the model to create a platform for strong future growth Strong growth in quality earnings, driven by the efficacy of the Vitality shared-value model and in line with the target operating model Focus on financial prudence and immunisation from a volatile interest rate environment 4 Strong performance removes need for VCP; and given strong growth dynamics a dividend is premature but will be revisited at the end of the financial year Normalised operating profit +22% to R5 930m Total income from non-insurance +51% to R2 528m -- 70 of 71 -- Discovery Limited Copyright © Discovery Ltd is the licensed controlling company of the designated Discovery Insurance Group. Registration number: 1999/007789/06. Companies in the Group are licensed insurers and authorised financial services providers. -- 71 of 71 --